Your Health Plan:
Your Health Plan:
Not SelectedACTEMRA (tocilizumab) is a biologic prescription drug for treatment of Rheumatoid Arthritis, Giant Cell Arteritis, Juvenile polyarthritis, Systemic onset juvenile chronic arthritis, Cytokine Release Syndrome and COVID19 (disease). ACTEMRA is a interleukin-6 receptor antagonist. It is available in the form of intravenous injection / subcutaneous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $600-3900.
Patient Assistance Prorgams and Coupons are found: